Ellison; Murielle Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ellison; Murielle Marie.The latest application filed is for "fg21 mutants and uses thereof".

Company Profile

3.18.17

Ellison; Murielle Marie - Thousand Oaks CA
Ellison; Murielle Marie - Thosand Oaks CA
- Thousand Oaks CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fg21 Mutants And Uses Thereof App 20210317176 - Belouski; Edward John ; et al.	2021-10-14
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants Grant 11,072,640 - Belouski , et al. July 27, 2	2021-07-27
FGF21 Mutants and Uses Thereof App 20190023757 - Belouski; Edward John ; et al.	2019-01-24
Methods of treating of diabetes and obesity using FGF21 mutants Grant 10,011,642 - Belouski , et al. July 3, 2	2018-07-03
Method of Treating or Ameliorating Type 1 Diabetes Using FGF21 App 20180000898 - Ellison; Murielle Marie ; et al.	2018-01-04
FGF21 mutants comprising a mutation at position 98, 171 and/or 180 Grant 9,493,530 - Belouski , et al. November 15, 2	2016-11-15
Fgf21 Mutants And Uses Thereof App 20160244497 - WALKER; Kenneth W. ; et al.	2016-08-25
Fgf Mutants And Uses Thereof App 20160168223 - Belouski; Edward John ; et al.	2016-06-16
FGF mutants with reduced proteolysis and aggregation Grant 9,273,106 - Belouski , et al. March 1, 2	2016-03-01
Fgf21 Mutants And Uses Thereof App 20140323396 - Belouski; Edward John ; et al.	2014-10-30
FGF21 polypeptides comprising two or more mutations and uses thereof Grant 8,835,385 - Belouski , et al. September 16, 2	2014-09-16
Fgf21 Mutants And Uses Thereof App 20140243503 - Belouski; Edward John ; et al.	2014-08-28
FGF 21 polypeptides comprising two or more mutations and uses thereof Grant 8,795,985 - Belouski , et al. August 5, 2	2014-08-05
Method of Treating or Ameliorating Type 1 Diabetes Using FGF21 App 20140213512 - Ellison; Murielle Marie ; et al.	2014-07-31
FGF21 mutant fusion polypeptides and uses thereof Grant 8,642,546 - Belouski , et al. February 4, 2	2014-02-04
FGF21 mutants multimers and uses thereof Grant 8,618,053 - Belouski , et al. December 31, 2	2013-12-31
FGF21 mutants multimers and uses thereof Grant 08618053 -	2013-12-31
FGF21 mutants and uses thereof Grant 8,410,051 - Belouski , et al. April 2, 2	2013-04-02
Uses of FGF21 polypeptides comprising two or more mutations Grant 8,361,963 - Belouski , et al. January 29, 2	2013-01-29
Fgf21 Mutants And Uses Thereof App 20120213779 - Belouski; Edward John ; et al.	2012-08-23
Fgf21 Mutants And Uses Thereof App 20120177646 - Belouski; Edward John ; et al.	2012-07-12
Fgf21 Mutants And Uses Thereof App 20120178685 - BELOUSKI; EDWARD JOHN ; et al.	2012-07-12
FGF21 mutants and uses thereof Grant 8,188,040 - Belouski , et al. May 29, 2	2012-05-29
Fgf21 Mutants And Uses Thereof App 20120093815 - BELOUSKI; EDWARD JOHN ; et al.	2012-04-19
Fgf21 Mutants And Uses Thereof App 20120087920 - Belouski; Edward John ; et al.	2012-04-12
Fgf21 Mutants And Uses Thereof App 20120052069 - Belouski; Edward John ; et al.	2012-03-01
Fgf21 Mutants And Uses Thereof App 20120003216 - BELOUSKI; EDWARD JOHN ; et al.	2012-01-05
FGF21 polypeptides comprising two or more mutations Grant 8,034,770 - Belouski , et al. October 11, 2	2011-10-11
Fgf21 Mutants And Uses Thereof App 20100285131 - Belouski; Edward John ; et al.	2010-11-11
FGF21 Mutants and uses thereof App 20090305986 - Belouski; Edward John ; et al.	2009-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.